2cureX AB (publ) (STO:2CUREX)
Sweden
· Delayed Price · Currency is SEK 1.340
-0.080 (-5.63%)
Mar 9, 2026, 4:50 PM CET
2cureX AB Revenue
2cureX AB had revenue of 250.00K SEK in the quarter ending June 30, 2024, a decrease of -63.07%. This brings the company's revenue in the last twelve months to 1.98M, down -49.75% year-over-year. In the year 2023, 2cureX AB had annual revenue of 2.95M, down -12.53%.
Revenue (ttm)
1.98M
Revenue Growth
-49.75%
P/S Ratio
17.02
Revenue / Employee
141.14K
Employees
14
Market Cap
33.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.95M | -422.00K | -12.53% |
| Dec 31, 2022 | 3.37M | -4.02M | -54.42% |
| Dec 31, 2021 | 7.39M | -8.00M | -51.98% |
| Dec 31, 2020 | 15.39M | 3.41M | 28.45% |
| Dec 31, 2019 | 11.98M | 4.31M | 56.12% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 21.13M |
| AcouSort AB | 10.43M |
| Pila Pharma AB | 1.13M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| Alzinova AB | 26.12M |
| Aptahem AB | 2.59M |
| Fluicell AB | 15.22M |
| Spago Nanomedical AB | 4.82M |